• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENCORE MEDICAL L.P. RSP; RSP, PRIMARY HUMERAL MONOBLOCK, 12MM X 108

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENCORE MEDICAL L.P. RSP; RSP, PRIMARY HUMERAL MONOBLOCK, 12MM X 108 Back to Search Results
Model Number 510-00-012
Health Effect - Clinical Code Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available (4581)
Date of Event 10/23/2020
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Additional reporting on this event will be provided as a supplemental report to this document as soon as it becomes available.
 
Event or Problem Description
Second revision surgery - the reason is unknown.
 
Additional Manufacturer Narrative
Manufacturer narrative: the reason for this revision surgery was reported as unknown reasons.The previous surgery and the surgery detailed in this event occurred 2.1 years apart.The healthcare professional indicated there was no delay in surgery and another suitable device was available for use.The revision surgery was completed as intended.The devices were disposed of at hospital and not made available to djo surgical for examination.A review of the device history records (dhr) show that the reported components used in the previous surgery, when released for use, met design and manufacturing requirements.There were no non-conforming material reports (ncmr) associated with the products that may have contributed to the reported event.The devices were verified to have gone through an acceptable sterilization process and were within its expiration date at the time of the previous surgery.Customer complaint history of the reported devices showed no present trends or on-going issues that are needing a review.The root cause of this complaint was a revision surgery for unknown reasons.There were no findings during this evaluation that indicate the reported devices were defective.No information was submitted with the complaint regarding pre-existing conditions of the patient or any activities the patient was involved in that may have contributed to the event.There are multiple factors that may contribute to an event that are outside the control of djo surgical.There are no indications of a product or process issue affecting implant safety or effectiveness.Additional reporting on this event will be provided as a supplemental report to this document as soon as it becomes available.
 
Additional Manufacturer Narrative
Additional reporting on this event will be provided as a supplemental report to this document if it becomes available.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RSP
Common Device Name
RSP, PRIMARY HUMERAL MONOBLOCK, 12MM X 108
Manufacturer (Section D)
ENCORE MEDICAL L.P.
9800 metric blvd
austin, tx 78758-5445
MDR Report Key10875576
Report Number1644408-2020-01079
Device Sequence Number11844515
Product Code PHX
UDI-Device Identifier00888912024839
UDI-Public(01)00888912024839
Combination Product (Y/N)N
Initial Reporter CountryUS
PMA/510(K) Number
K100741
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2018
Device Explanted Year2020
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source company representative
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup,Followup
Report Date (Section B) 06/09/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date03/20/2024
Device Model Number510-00-012
Device Catalogue Number510-00-012
Device Lot Number981F1339
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 10/23/2020
Supplement Date Received by Manufacturer02/04/2021
05/18/2021
Initial Report FDA Received Date11/20/2020
Supplement Report FDA Received Date03/05/2021
06/09/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
506-03-118 LOT 832C1467.; 506-03-118 LOT 832C1467.; 506-03-118 LOT 832C1467.; 506-03-122 LOT 833C1445.; 506-03-122 LOT 833C1445.; 506-03-122 LOT 833C1445.; 506-03-134 LOT 836C1222.; 506-03-134 LOT 836C1222.; 506-03-134 LOT 836C1222.; 506-03-138 LOT 837C1088.; 506-03-138 LOT 837C1088.; 506-03-138 LOT 837C1088.; 508-01-040 LOT 861C1032.; 508-01-040 LOT 861C1032.; 508-01-432 LOT 922F1036.; 508-01-440 LOT 924F1901.; 508-32-101 LOT 862C2436.; 508-32-104 LOT 866C2479.; 508-32-104 LOT 866C2479.; 508-32-104 LOT 866C2479.; 508-40-101 LOT 875C1214.; 508-40-101 LOT 875C1214.; 510-08-000 LOT 142G1254.; 510-08-000 LOT 142G1264.; 510-08-000 LOT 142G1264.; 506-03-118 LOT 832C1467; 506-03-122 LOT 833C1445; 506-03-134 LOT 836C1222; 506-03-138 LOT 837C1088; 508-01-040 LOT 861C1032; 508-01-440 LOT 924F1901; 508-32-104 LOT 866C2479; 508-40-101 LOT 875C1214; 510-08-000 LOT 142G1264
Outcome Attributed to Adverse Event Required Intervention;
Patient Age67 YR
-
-